London, UK, May 4, 2007 - SkyePharma PLC (LSE: SKP; NASDAQ: SKYE) announced
today that it will delist its American Depositary Shares (the "ADSs"), each
representing the right to receive ten ordinary shares of ten pence each of
SkyePharma, from The NASDAQ Stock Market and, pursuant to the newly-adopted Rule
12h-6(a) under the U.S. Securities Exchange Act of 1934 (the "Exchange Act"),
deregister and terminate SkyePharma's reporting obligations under Sections 13(a)
and 15(d) of Exchange Act.
